US Bancorp’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.3M Buy
21,327
+1,006
+5% +$267K 0.01% 430
2026
Q1
$2.23M Sell
20,321
-115
-0.6% -$16.4K ﹤0.01% 837
2025
Q4
$3.4M Buy
20,436
+2,319
+13% +$388K ﹤0.01% 713
2025
Q3
$3.55M Buy
18,117
+8,139
+82% +$1.34M ﹤0.01% 696
2025
Q2
$902K Buy
9,978
+6,887
+223% +$544K ﹤0.01% 1164
2025
Q1
$184K Sell
3,091
-3,259
-51% -$301K ﹤0.01% 2048
2024
Q4
$841K Buy
6,350
+5,477
+627% +$514K ﹤0.01% 1208
2024
Q3
$45.7K Buy
+873
New +$41K ﹤0.01% 2784

Other funds holding ALAB

US Bancorp's ALAB Position: Q2 2026 in Review

US Bancorp increased its Astera Labs (ALAB) stake by 5% in Q2 2026, buying an estimated $267K and bringing the position to 21,327 shares worth $10.3M. The position accounts for 0.01% of the portfolio, ranked #430.

US Bancorp first reported a position in ALAB in Q3 2024 and has held it in 8 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • US Bancorp held 21,327 shares of Astera Labs worth $10.3M as of Q2 2026.
  • US Bancorp bought 1,006 Astera Labs shares in Q2 2026, an estimated $267K.
  • Astera Labs made up 0.01% of US Bancorp's portfolio in Q2 2026, its #430 holding.
  • US Bancorp first reported a position in Astera Labs in Q3 2024 and has held it in 8 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.